Collectively, our study establishes a novel regulatory axis, ZNF384/KIF13B/STT3A/CTSD/THBS1, essential for macrophage-hepatocyte crosstalk during MASLD progression and providing potential therapeutic targets for the treatment of MASLD.
Lu et al. (Wed,) studied this question.